Simpler Grants.gov #PAR-25-336

NIH Grant for Translational Nanotechnology Cancer Interventions Research

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is seeking applications for the "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI) program. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - Program Focus: - Supports advanced pre-clinical research on nanotechnology-based cancer diagnostics and therapeutics - Aims to mature experimental nanomedicines using nanoparticles and nano-devices - Seeks to improve cancer treatment effectiveness through innovative structural designs and targeted delivery of therapeutic or diagnostic agents - Projects should advance interventions to a stage suitable for further development in NCI translational programs (e.g., NExT) - Products/Services Requested: - No specific products, part numbers, or OEMs are identified - Research and development of nanotechnology-based cancer interventions - Unique/Notable Requirements: - Open to a wide range of applicants, including government entities, educational institutions, nonprofits, and businesses - Funding instrument is a grant, not a contract - Emphasis on translational research to bridge pre-clinical work and clinical development - No OEMs or vendors are specified in this opportunity

Description

This Notice of Funding Opportunity (NOFO) from the National Cancer Institute (NCI) supports advanced pre-clinical research for translating nanotechnology-based cancer diagnostics and therapeutics. The TTNCI awards aim to mature experimental nanomedicines that use nanoparticles and nano-devices to improve cancer treatment effectiveness. The awards are intended to advance these nanotechnology interventions to a stage suitable for further development through NCI translational programs such as the Experimental Therapeutics (NExT) program.

View original listing